Last viewed: MRNA

Prices are updated after-hours

MRNA Nasdaq

Moderna, Inc.

MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

(0.0% 1d) (-2.3% 1m) (-20.0% 1y) (0.0% 2d) (3.3% 3d) (6.4% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 41,664,959,378
http://www.modernatx.com
Sec Filling | Patents | 830 employees

(US) Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

vaccine cancer

add to watch list Paper trade email alert is off

Press-releases

Moderna and OpenAI Collaborate To Advance mRNA Medicine
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 0.0% | O: 2.97% H: 0.0% C: 0.0%
mrna

Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 6.39% | O: 1.36% H: 2.57% C: 1.62%
covid-19 contract million brazil

Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 3.95% | O: 1.3% H: 0.0% C: -1.62%
first report financial results

Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 6.6% | O: 1.46% H: 3.2% C: -0.41%
ABUS | $2.74 -0.36% -0.36% 340K

|

Health Technology

| 9.56% | O: 16.73% H: 6.14% C: 2.39%
patent construction biopharma ongoing

Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 4.13% | O: -0.59% H: 2.09% C: -1.74%
rna-3927 mrna therapy

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480

|

Health Technology

| -5.71% | O: -0.26% H: 0.0% C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M

|

Health Technology

| -4.35% | O: 1.06% H: 0.0% C: 0.0%
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 0.45% | O: 2.02% H: 1.41% C: 0.92%
vaccine trials

Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
BX | $123.78 -0.43% -0.07% 2M

|

| -2.79% | O: 1.27% H: 1.14% C: 1.07%
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 0.45% | O: 2.02% H: 1.41% C: 0.92%
life influenza sciences collaboration program

Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| -2.26% | O: 1.29% H: 0.0% C: -3.93%
covid-19 vaccine positive trial results

Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Published: 2024-03-19 (Crawled : 12:30) - prnewswire.com
OMGA | $2.335 -0.21% -0.21% 200K

|

| -33.52% | O: 0.0% H: 1.42% C: -2.56%
SANA | $8.58 6.06% 5.71% 1.2M

|

| -9.2% | O: -1.57% H: 1.48% C: -1.37%
MCRB | $0.7295 -4.01% -4.18% 5.8M

|

Health Technology

| 0.22% | O: 0.22% H: 12.36% C: 6.11%
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 3.48% | O: -0.35% H: 1.59% C: 1.16%
FHTX | $5.21 0.97% 0.96% 110K

|

Health Technology

| -12.98% | O: -1.01% H: 5.45% C: 3.41%
DNLI | $15.55 -3.48% -3.6% 940K

|

Health Technology

| -19.81% | O: -0.75% H: 3.41% C: 3.01%
companies

Moderna to Present at Upcoming Investor Conferences in March 2024
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M

|

Health Technology

| 12.15% | O: -1.25% H: 4.49% C: 2.61%

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0000950170-24-046164	4	2024-04-19	2024-04-17	Sell	S	282	2056931
0000950170-24-046164	4	2024-04-19	2024-04-17	Sell	S	6475	2057213
0000950170-24-046164	4	2024-04-19	2024-04-17	Sell	S	8243	2063688
0001127602-24-012991	4	2024-04-16	2024-04-15	Sell	S	15000	1486241
0000950170-24-044186	4	2024-04-12	2024-04-10	Sell	S	389	2071931
0000950170-24-044186	4	2024-04-12	2024-04-10	Sell	S	748	2072320
0000950170-24-044186	4	2024-04-12	2024-04-10	Sell	S	7512	2073068
0000950170-24-044186	4	2024-04-12	2024-04-10	Sell	S	6351	2080580

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M

|

Consumer Services

BOF | $1.99 70.09% 41.21% 110M

|

ILAG | $0.51 6.03% 40.62% 1.7M

|

LICN | $0.941 68.04% 40.49% 15M

|

AMST | $3.31 65.5% 39.58% 70M

|

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M

|

Technology Services

WIMI | $1.15 58.53% 36.92% 19M

|

Technology Services

AIH | $0.45 12.5% 30.92% 320K

|

Health Services

MULN | News | $3.78 38.46% 27.78% 13M

|

RILY | $29.86 37.48% 27.26% 12M

|

Last 48 Hours Insiders Buying

RKT P 347 | $12.55 -0.63% 0.48% 1.7M

|

| 22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K

|

| 22:00
TGEN P 10000 | $0.685 39.71% 6.6K

|

| 20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K

|

| 15:30
RMCF | $3.54 0.28% 7.1K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar